Sanofi Biotechnology;Regeneron Pharmaceuticals, Inc.
发明人:
申请号：
EP12769684.7
公开号：
EP2766039B1
申请日:
2012.10.10
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
The present invention provides compositions and methods of treating and improving the symptoms of rheumatoid arthritis using an antibody or antigen-binding fragment thereof that specifically binds human interleukin-6 receptor (hIL-6R) with a DMARD.
